Works by Ho, Alan L

Results: 24

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

Published in:

Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080

By:

Le, Xiuning;
Baik, Christina;
Bauman, Jessica;
Gilbert, Jill;
Brose, Marcia S;
Grilley-Olson, Juneko E;
Patil, Tejas;
McDermott, Ray;
Raez, Luis E;
Johnson, Jennifer M;
Shen, Lin;
Tahara, Makoto;
Ho, Alan L;
Norenberg, Ricarda;
Dima, Laura;
Brega, Nicoletta;
Drilon, Alexander;
Hong, David S

Publication type:

Article

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 662, doi. 10.2967/jnumed.114.150607

By:

Nagarajah, James;
Ho, Alan L.;
Tuttle, R. Michael;
Weber, Wolfgang A.;
Grewal, Ravinder K.

Publication type:

Article

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

Published in:

JAMA Network Open, 2022, v. 5, n. 11, p. e2241538, doi. 10.1001/jamanetworkopen.2022.41538

By:

Youssef, Irini;
Yoon, Jennifer;
Mohamed, Nader;
Zakeri, Kaveh;
Press, Robert H.;
Chen, Linda;
Gelblum, Daphna Y.;
McBride, Sean M.;
Tsai, Chiaojung Jillian;
Riaz, Nadeem;
Yu, Yao;
Cohen, Marc A.;
Dunn, Lara Ann;
Ho, Alan L.;
Wong, Richard J.;
Michel, Loren S.;
Boyle, Jay O.;
Singh, Bhuvanesh;
Kriplani, Anuja;
Ganly, Ian

Publication type:

Article

The evolving landscape of salivary gland tumors.

Published in:

CA: A Cancer Journal for Clinicians, 2023, v. 73, n. 6, p. 597, doi. 10.3322/caac.21807

By:

Steuer, Conor E.;
Hanna, Glenn J.;
Viswanathan, Kartik;
Bates, James E.;
Kaka, Azeem S.;
Schmitt, Nicole C.;
Ho, Alan L.;
Saba, Nabil F.

Publication type:

Article

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer.

Published in:

CA: A Cancer Journal for Clinicians, 2023, v. 73, n. 2, p. 164, doi. 10.3322/caac.21758

By:

Kang, Jung Julie;
Yu, Yao;
Chen, Linda;
Zakeri, Kaveh;
Gelblum, Daphna Yael;
McBride, Sean Matthew;
Riaz, Nadeem;
Tsai, C. Jillian;
Kriplani, Anuja;
Hung, Tony K. W.;
Fetten, James V.;
Dunn, Lara A.;
Ho, Alan L.;
Boyle, Jay O.;
Ganly, Ian S.;
Singh, Bhuvanesh;
Sherman, Eric J.;
Pfister, David G.;
Wong, Richard J.;
Lee, Nancy Y.

Publication type:

Article

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy.

Published in:

Journal of Skin Cancer, 2014, p. 1, doi. 10.1155/2014/284582

By:

Samstein, Robert M.;
Ho, Alan L.;
Lee, Nancy Y.;
Barker, Christopher A.

Publication type:

Article

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.

Published in:

2016

By:

Nagarajah, James;
Mina Le;
Knauf, Jeffrey A.;
Ferrandino, Giuseppe;
Montero-Conde, Cristina;
Pillarsetty, Nagavarakishore;
Bolaender, Alexander;
Irwin, Christopher;
Krishnamoorthy, Gnana Prakasam;
Saqcena, Mahesh;
Larson, Steven M.;
Ho, Alan L.;
Seshan, Venkatraman;
Nobuya Ishii;
Carrasco, Nancy;
Rosen, Neal;
Weber, Wolfgang A.;
Fagin, James A.;
Le, Mina;
Ishii, Nobuya

Publication type:

journal article

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).

Published in:

Cancer (0008543X), 2024, v. 130, n. 5, p. 702, doi. 10.1002/cncr.35103

By:

Ho, Alan L.;
Foster, Nathan R.;
Deraje Vasudeva, Shyamprasad;
Katabi, Nora;
Antonescu, Cristina R.;
Frenette, Gary P.;
Pfister, David G.;
Erlichman, Charles;
Schwartz, Gary K.

Publication type:

Article

[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.

Published in:

2024

By:

Backhaus, Philipp;
Pentlow, Keith S.;
Ho, Alan L;
Mauguen, Audrey;
Fagin, James A;
Pillarsetty, Naga Vara Kishore;
Lyashchenko, Serge K.;
Burnazi, Eva;
Ghossein, Ronald A.;
Chhabra, Shalini;
Abusamra, Murad;
Larson, Steven M.;
Schöder, Heiko;
O'Donoghue, Joseph;
Weber, Wolfgang;
Grewal, Ravinder K.

Publication type:

Case Study

Moving toward a better understanding of radioiodine action.

Published in:

Endocrine (1355008X), 2013, v. 44, n. 3, p. 553, doi. 10.1007/s12020-013-0024-x

By:

Ho, Alan L.

Publication type:

Article

Therapeutic strategies for systemic therapies of human papillomavirus‐related oropharyngeal cancer.

Published in:

Journal of Surgical Oncology, 2021, v. 124, n. 6, p. 952, doi. 10.1002/jso.26688

By:

Hung, Tony K. W.;
Ho, Alan L.;
Pfister, David G.

Publication type:

Article

Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.

Published in:

Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/60695

By:

Hung, Tony K W;
Kuperman, Gilad J;
Sherman, Eric J;
Ho, Alan L;
Weng, Chunhua;
Pfister, David G;
Mao, Jun J

Publication type:

Article

Androgen Receptor Signaling in Salivary Gland Cancer.

Published in:

Cancers, 2017, v. 9, n. 2, p. 17, doi. 10.3390/cancers9020017

By:

Watson, Philip A.;
Dalin, Martin G.;
Morris, Luc G. T.;
Ho, Alan L.

Publication type:

Article

The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.

Published in:

Cell Cycle, 2012, v. 11, n. 4, p. 807, doi. 10.4161/cc.11.4.19323

By:

Nair, Jayasree S.;
Ho, Alan L.;
Schwartz, Gary K.

Publication type:

Article

Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.

Published in:

Thyroid, 2025, v. 35, n. 6, p. 633, doi. 10.1089/thy.2025.0052

By:

Choi, Justin;
Sherman, Eric;
Dee, Edward Christopher;
Treechairusame, Teeradon;
Zakeri, Kaveh;
Kang, Jung Julie;
Yu, Yao;
Chen, Linda;
Shamseddine, Achraf;
McBride, Sean M.;
Riaz, Nadeem;
Ho, Alan L.;
Tuttle, R. Michael;
Fagin, James;
Sabra, Mona;
Cracchiolo, Jennifer;
Shaha, Ashok;
Wong, Richard J.;
Ghossein, Ronald;
Katabi, Nora

Publication type:

Article

Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.

Published in:

Thyroid, 2022, v. 32, n. 3, p. 273, doi. 10.1089/thy.2021.0565

By:

Tchekmedyian, Vatche;
Dunn, Lara;
Sherman, Eric;
Baxi, Shrujal S.;
Grewal, Ravinder K.;
Larson, Steven M.;
Pentlow, Keith S.;
Haque, Sofia;
Tuttle, R. Michael;
Sabra, Mona M.;
Fish, Stephanie;
Boucai, Laura;
Walters, Jamie;
Ghossein, Ronald A.;
Seshan, Venkatraman E.;
Knauf, Jeffrey A.;
Pfister, David G.;
Fagin, James A.;
Ho, Alan L.

Publication type:

Article

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Published in:

2020

By:

Hanna, Glenn J.;
Guenette, Jeffrey P.;
Chau, Nicole G.;
Sayehli, Cyrus M.;
Wilhelm, Christian;
Metcalf, Robert;
Wong, Deborah J.;
Brose, Marcia;
Razaq, Mohammad;
Pérez‐Ruiz, Elisabeth;
Cohen, Ezra E. W.;
Aggarwal, Rahul;
Scholz, Catherine;
Gualberto, Antonio;
Ho, Alan L.;
Pérez-Ruiz, Elisabeth

Publication type:

journal article

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.

Published in:

2019

By:

Sherman, Eric J.;
Dunn, Lara A.;
Schöder, Heiko;
Ho, Alan L.;
Baxi, Shrujal S.;
Ghossein, Ronald A.;
Haque, Sofia S.;
Sima, Cami;
Tuttle, Robert Michael;
Pfister, David G.

Publication type:

journal article

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

Published in:

2017

By:

Sherman, Eric J.;
Dunn, Lara A.;
Ho, Alan L.;
Baxi, Shrujal S.;
Ghossein, Ronald A.;
Fury, Matthew G.;
Haque, Sofia;
Sima, Cami S.;
Cullen, Grace;
Fagin, James A.;
Pfister, David G.

Publication type:

journal article

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Published in:

Cancer (0008543X), 2013, v. 119, n. 10, p. 1823, doi. 10.1002/cncr.27986

By:

Fury, Matthew G.;
Sherman, Eric;
Ho, Alan L.;
Xiao, Han;
Tsai, Frank;
Nwankwo, Oby;
Sima, Camelia;
Heguy, Adrian;
Katabi, Nora;
Haque, Sofia;
Pfister, David G.

Publication type:

Article

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Published in:

Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01178-z

By:

Dalin, Martin G.;
Katabi, Nora;
Persson, Marta;
Ken-Wing Lee;
Makarov, Vladimir;
Desrichard, Alexis;
Walsh, Logan A.;
West, Lyndsay;
Nadeem, Zaineb;
Ramaswami, Deepa;
Havel, Jonathan J.;
Fengshen Kuo;
Chadalavada, Kalyani;
Nanjangud, Gouri J.;
Ganly, Ian;
Riaz, Nadeem;
Ho, Alan L.;
Antonescu, Cristina R.;
Ghossein, Ronald;
Stenman, Göran

Publication type:

Article

Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.

Published in:

Histopathology, 2025, v. 86, n. 5, p. 728, doi. 10.1111/his.15380

By:

Chu, Ying‐Hsia;
Katabi, Nora;
Sukhadia, Purvil;
Mullaney, Kerry A;
Zaidinski, Michael;
Cracchiolo, Jeniffer R;
Xu, Bin;
Ghossein, Ronald A;
Ho, Alan L;
DiNapoli, Sara E;
Ladanyi, Marc;
Dogan, Snjezana

Publication type:

Article

Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.

Published in:

PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040439

By:

Ho, Alan L.;
Musi, Elgilda;
Ambrosini, Grazia;
Nair, Jayasree S.;
Vasudeva, Shyamprasad Deraje;
de Stanchina, Elisa;
Schwartz, Gary K.

Publication type:

Article

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. 830, doi. 10.1210/clinem/dgae512

By:

Konda, Bhavana;
Sherman, Eric J;
Massarelli, Erminia;
Nieva, Jorge;
Muzaffar, Jameel;
Morris, John C;
Ryder, Mabel;
Ho, Alan L;
Agulnik, Mark;
Wei, Lai;
Handley, Demond;
Moses, Catherine;
Jacob, Rajani;
Wright, John;
Streicher, Howard;
Carson, William;
Shah, Manisha H

Publication type:

Article

Works by Ho, Alan L

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

Correlation of BRAF<sup>V600E</sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study.

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

The evolving landscape of salivary gland tumors.

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer.

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy.

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).

[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.

Moving toward a better understanding of radioiodine action.

Therapeutic strategies for systemic therapies of human papillomavirus‐related oropharyngeal cancer.

Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.

Androgen Receptor Signaling in Salivary Gland Cancer.

The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.

Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.

Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.

Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.